Editorial: Digoxin--the regulatory viewpoint.
D001702:Biopharmaceutics; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood / Q000592:standards*; D004345:Drug Industry; D006801:Humans; D007275:Injections, Intravenous; D007880:Legislation, Drug; D012996:Solutions; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration
D012996:Solutions; D013607:Tablets; D004077:Digoxin